Epileptic Seizures After Allogeneic Hematopoietic Stem Cell Transplantation

Area of Science:

• Hematology
• Neurology
• Transplantation Medicine

Background:

• Allogeneic hematopoietic stem cell transplantation (HSCT) techniques have advanced, increasing patient numbers.
• HSCT recipients face high risks of complications, including neurological involvement.
• Epileptic seizures are a common and serious neurological complication post-HSCT.

Purpose of the Study:

• To review the incidence of seizures after allogeneic HSCT.
• To summarize the etiologies, mechanisms, clinical manifestations, treatment, and prognosis of post-HSCT seizures.
• To enhance clinical understanding and management of seizures in HSCT recipients.

Main Methods:

• Literature review of studies on seizures following allogeneic HSCT.
• Synthesis of data on incidence, causes, clinical presentation, and outcomes.
• Analysis of current therapeutic strategies and prognostic factors.

Main Results:

• Seizures are a frequent complication impacting survival and quality of life.
• Multiple etiologies contribute to post-HSCT seizures, including infections, metabolic disturbances, and medication toxicity.
• Early recognition and appropriate management are crucial for improving patient prognosis.

Conclusions:

• Understanding the spectrum of seizures post-HSCT is vital for timely intervention.
• Improved diagnostic and therapeutic approaches can mitigate the impact of seizures.
• Further research is needed to optimize seizure prevention and treatment strategies in HSCT patients.